TY  - GEN
AU  - Raschi,E
AU  - Poluzzi,E
AU  - Salvo,F
AU  - Pariente,A
AU  - De Ponti,F
AU  - Marchesini,G
AU  - Moretti,U
TI  - Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
SN  - 1590-3729
PY  - 2019///0314
KW  - Adverse Drug Reaction Reporting Systems
KW  - Clinical Decision-Making
KW  - Diabetes Mellitus, Type 2
KW  - diagnosis
KW  - Humans
KW  - Patient Selection
KW  - Pharmacovigilance
KW  - Risk Assessment
KW  - Risk Factors
KW  - Sodium-Glucose Transporter 2 Inhibitors
KW  - adverse effects
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1016/j.numecd.2018.02.014
ER  -